Premium
Kinetics of anti‐SARS‐CoV ‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy
Author(s) -
Kastritis Efstathios,
Terpos Evangelos,
Evangelakou Zoi,
Theodorakakou Foteini,
Fotiou Despina,
Manola Maria S.,
Gianniou Despoina D.,
Bagratuni Tina,
Kanellias Nikolaos,
Migkou Magdalini,
Gavriatopoulou Maria,
Trougakos Ioannis P.,
Dimopoulos Meletios A.
Publication year - 2022
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26406
Subject(s) - medicine , immunology , plasma cell , amyloidosis , vaccination , monoclonal gammopathy of undetermined significance , immune system , antibody , monoclonal , monoclonal antibody